Lesaffre and Meiogenix to develop yeasts for ‘new and existing’ bakery processes

By Vince Bamford

- Last updated on GMT

Baking industry is continuously changing, said Lesaffre. Photo: iStock - SafakOguz
Baking industry is continuously changing, said Lesaffre. Photo: iStock - SafakOguz
Biotech firm Meiogenix and yeast supplier Lesaffre are to work together to develop new baker’s yeasts.

Under a new collaboration agreement, Meiogenix aims to use its non-GM technology to discover novel yeast strains with improved industrial properties.

These will then be industrialized by Lesaffre, which told BakeryandSnacks they would be hoping to improve baker’s yeasts and offer yeasts “even more suitable to existing and newly introduced baking recipes and processes.​”

This is part of Lesaffre’s strategy to continuously adapt its portfolio to offer yeasts that suit the best the changes that are taking place in the baking industry continuously​,” it added.

Genetic engineering techniques

Advances in genetic engineering techniques such as CRISPR/CAS9 could have “unprecedented impact​” on the development of novel yeast strains, said the businesses, but concerns about genetically modified organisms in the food and beverage industry were still a major hurdle for development and commercialization.

Meiogenix said its proprietary PhoeniX technology controls the process of natural meiotic recombination and efficiently generates non-GM recombined yeast cells, particularly for industrial strains where meiosis is impeded.

The businesses

Meiogenix: ​Paris-based Meiogenix is a spin-off of the Institut Curie and agricultural research institute INRA, which aims develop breeding technologies to increase the genetic diversity of organisms.

Lesaffre: ​A global yeasts and fermentation business, Lesaffre designs, manufactures and markets solutions for baking, health care and biotechnology. It has a turnover of more than €1.8bn ($2bn).

'Not yet an accepted option'

We believe PhoeniX can have a major impact in the yeast industry, especially for food applications where mainstream genetic engineering technologies are not yet an accepted option​,” said Meiogenix co-founder and CEO Giacomo Bastianelli.

He added the collaboration with Lesaffre would give his business the chance to “put into play​” the yeast technologies it had developed.

Lesaffre R&D Biotech Center director Didier Colavizza said Meiogenix’s technology gave Lesaffre an opportunity to produce more diversity in yeast.

As an alternative to mutagenesis, this technique can improve yeasts and be applied in many fields from baking yeast to biofuels,​” he added.

Related news

Show more

Related products

show more

Sweeten Your Treats with Sustainable Syrups

Sweeten Your Treats with Sustainable Syrups

Content provided by Green Plains Inc. | 03-Oct-2024 | Insight Guide

Elevate your products with Green Plains’ premium, low carbon-intensity corn syrups. Drop-in replacements with an up to 40% lower carbon footprint than...

Breakthrough ingredients for better-for-you bread

Breakthrough ingredients for better-for-you bread

Content provided by ADM | 03-Oct-2024 | White Paper

Our new flour blend is a carefully curated blend of clinically studied ingredients to help you create better-for-you bread that tastes great to help you...

Leveraging the Power of Enzymes to Maximize Value

Leveraging the Power of Enzymes to Maximize Value

Content provided by IFF | 18-Sep-2024 | Application Note

In today’s dynamic bakery industry, excelling requires more than just great taste. With tightening budgets and rising expectations, manufacturers must...

Improve texture, volume & appearance with Corbion

Improve texture, volume & appearance with Corbion

Content provided by Corbion | 02-Sep-2024 | White Paper

Consumers think twice about products that vary in quality. Delivering superior experiences consistently is the best way to keep consumers satisfied and...

Related suppliers

Follow us

Products

View more

Webinars